Brief: Seelos Therapeutics Gets Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
23/11/2022 21:42
Nov 23 (Reuters) - Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS - ON NOV 21, CO GOT NOTICE OF
DELISTING OR
FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM
NASDAQ
Source: (shorturl.at/RZ014)
Further company coverage: SEEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio